CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 22 No. 4
Special Issue on Targeted Therapy 

In Memoriam: Dr. M. Judah Folkman

By
William W. Li, MD
President and Medical Director
The Angiogenesis Foundation
Cambridge, Massachusetts | April 15, 2008
Dr. William Li reflects on the recent passing of the ‘Father of Angiogenesis,’ whose work founded an entire branch of targeted cancer therapy

It is with great sadness that the Angiogenesis Foundation reflects on the passing of Dr. Judah Folkman, founder and pioneer of the field of angiogenesis research. His sudden and unexpected death on January 14 comes as a great shock to all who trained with and were students of this remarkable surgeon, scientist, teacher, and visionary. The Angiogenesis Foundation extends its deepest condolences to Dr. Folkman’s wife, Paula, and his family.

Dr. Folkman’s pioneering research on tumor angiogenesis began in the 1960s, and revolutionized the modern understanding of cancer, paving the way for the development of a number of life-prolonging cancer therapies in use today. He was one of the greatest scientific minds of our time. His vision inspired the creation of the Angiogenesis Foundation 14 years ago as a nonprofit organization dedicated to advancing the new field of angiogenesis treatments for more than 70 different diseases. Dr. Folkman’s vision, mentorship and guidance will be greatly missed by those of us fortunate to have known and worked with him.

Dr. Folkman thrice served as a faculty member for the Angiogenesis Foundation, delivering keynote addresses alongside Nobel Laureates James Watson, Louis J. Ignarro, and H. Robert Horvitz, in the Foundation’s Annual International Conference on Antiangiogenesis, held in the fall each year. Dr. Folkman referred patients and friends to the Foundation for consultation on antiangiogenic therapy. Dr. Folkman quietly provided important guidance and encouragement to our organization. He advised us behind the scenes and gave us his insights into challenges and opportunities he saw in the field; championed the Foundation’s mission to influential individuals and prospective donors; and donated books and manuscripts to our library. He publicly recognized the Foundation at major conferences before world leading scientists and industry leaders involved in angiogenesis research. In 2003, the Angiogenesis Foundation honored Dr. Folkman with a Lifetime Scientific Achievement Award, presented to him by then Massachusetts Governor Mitt Romney.

Dr. Folkman had the good fortune to witness the field he pioneered evolve, on a global scale, into a major force in modern science and medicine. He lived to see his ideas from the laboratory become translated into real, practical treatments that are today helping patients afflicted by cancer, age-related macular degeneration, diabetic wounds, and other serious diseases.

At the Angiogenesis Foundation, we will honor Dr. Folkman’s memory by continuing our commitment to advance the field that he established and helping to realize his vision of angiogenesis as a unifying concept in 21st century medicine.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





Reprinted, with permission of Dr. Li and the Angiogenesis Foundation, from the Foundation’s website (www.angio.org). The Angiogenesis Foundation’s mission is to improve global health by advancing the field of angiogenesis-based medicine.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy